Global AI in Life Extension Market By Offerings (Software Solutions, Services); By Technology (Advanced bioinformatics methods, Deep learning algorithms, Machine Learning, Others); By Applications (Drugs Design and Redesign, Biomarker development, Disease target identification, Generation of synthetic biology (generative biology), novel molecules (generative chemistry) data, Clinical trial Prediction Outcomes); By End Users(Pharmaceutical Companies, Universities And Hospital Networks, Cosmetic And Regenerative Medicine Companies, Food Companies, Research Centers and Laboratories, Clinicians and Drug Developers, Others); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
The global AI in life extension market is growing at an estimated CAGR of 36.5% over the forecast period. Human thinking knows no limitations and the amount of progress seen by technology is a proof of it. Things that seemed impossible years back are now performed with utmost ease. It has been an integral part of human evolution and development by every sector can be credited to the technology. The introduction of artificial intelligence couple of years back has completely changed the dynamics of majority of industries. Artificial intelligence (AI) happens to be a technology that replicates or simulates human intelligence in machines. This technology when used in the health sector is actually doing wonders. AI in life extension market is taking massive strides on the path of growth.
The COVID-19 pandemic that claimed lives of millions and dented the world economy, helped the AI in life extension market achieve some momentum. Due to collapse in existing healthcare infrastructure and need for development of new drugs, this market saw massive growth.
Offerings Outlook
On the basis of offerings, the AI in life extension market has been divided into software solutions and services. The products are relatively new and haven’t even scratched the surface, and hence the software solutions segment accounts for majority of revenue generated by this market. New companies are entering this domain which is helping it grow.
Technology Outlook
On the basis of technology, the AI in life extension market has been segmented into advanced bioinformatics methods, deep learning algorithms, machine learning and others. Bioinformatics primarily happens to be the study of bio-data regarding computer science, biology, biotechnology and maths. On the other hand, deep learning algorithms are part of machine learning methods that are data-intensive.
Global AI in Life Extension Market Revenue & Forecast, (US$ Million), 2022 – 2030
Application Outlook
On the basis of applications, the AI in life extension market has been categorised into drug design and redesign, biomarker development, disease target identification, generation of synthetic biology (generative biology), novel molecules (generative chemistry) and clinical trial prediction outcomes. AI plays an important role in designing and redesigning of new drugs. It helps in accessing new biology, enhanced novel chemistry that ensure optimization of costs along with good rate of success.
End Users Outlook
The end user segment of the AI in life extension market has been divided into pharmaceutical companies, universities and hospital networks, cosmetic and regenerative medicine companies, food companies, research centers and laboratories, clinicians and drug developers, and others. While food companies are using AI in multiple purposes like quality check, the pharmaceutical companies dominate in terms of market share. These companies are investing heavily to ensure higher production rates, better quality of drugs and cut down the cost.
Region Outlook
On the basis of region, the AI in life extension market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America generates maximum amount of money for this market. Presence of top pharma, medical research companies and hospitals along with companies that provide software that run on AI help this market flourish. Countries like the US and Canada are seeing tremendous progress for this market.
Competitive Landscape
The report provides both, qualitative and quantitative research of AI in life extension market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the global AI in life extension market are listed below:
- AgeX Therapeutics, Inc.
- Human Longevity, Inc.
- Juvenescence Ltd.
- Life Extension (Insilico Medicine)
- resTORbio
- Samumed
- UNITY Biotechnology
- Other Market Participants
Global AI in Life Extension Market
By Offerings
- Software
- Services
By Technology
- Advanced bioinformatics methods
- Deep learning algorithms
- Machine Learning
- Others
By Applications
- Drugs Design and Redesign
- Biomarket development
- Disease target identification
- Generate of synthetic biology (generation biology)
- Novel molecules (generative chemistry) data
- Clinical trial Prediction Outcomes
By End Users
- Pharmaceutical Companies
- Universities and hospital networks
- Cosmetic and Regenerative medicine companies
- Food Companies
- Research Centers and Laboratories
- Clinicians and Drug Developers
- Others
By Region
- North America
- S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2020
1.2.2. Base Year: 2021
1.2.3. Forecast Years: 2022 – 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Artificial Intelligence in Life Extension Market
6. Market Synopsis: Artificial Intelligence in Life Extension Market
7. Artificial Intelligence in Life Extension Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Artificial Intelligence in Life Extension Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators: Artificial Intelligence in Life Extension Market
7.6. Porter’s Five Force Analysis
7.7. Impact of Covid -19 on Artificial Intelligence in Life Extension Market
8. Global Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2022 – 2030
8.1. Overview
8.1.1. Global Artificial Intelligence in Life Extension Market Revenue (US$ Mn)
8.2. Global Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1. Software Solutions
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 – 2021
8.2.1.3. Market Forecast, 2022 – 2030
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market Estimation, 2015 – 2021
8.2.1.5.1.2. Market Forecast, 2022 – 2030
8.2.1.5.2. Europe
8.2.1.5.2.1. Market Estimation, 2015 – 2021
8.2.1.5.2.2. Market Forecast, 2022 – 2030
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market Estimation, 2015 – 2021
8.2.1.5.3.2. Market Forecast, 2022 – 2030
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market Estimation, 2015 – 2021
8.2.1.5.4.2. Market Forecast, 2022 – 2030
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market Estimation, 2015 – 2021
8.2.1.5.5.2. Market Forecast, 2022 – 2030
8.2.2. Services
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 – 2021
8.2.2.3. Market Forecast, 2022 – 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market Estimation, 2015 – 2021
8.2.2.5.1.2. Market Forecast, 2022 – 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market Estimation, 2015 – 2021
8.2.2.5.2.2. Market Forecast, 2022 – 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market Estimation, 2015 – 2021
8.2.2.5.3.2. Market Forecast, 2022 – 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market Estimation, 2015 – 2021
8.2.2.5.4.2. Market Forecast, 2022 – 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market Estimation, 2015 – 2021
8.2.2.5.5.2. Market Forecast, 2022 – 2030
8.3. Key Segment for Channeling Investments
8.3.1. By Offerings
9. Global Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2022 – 2030
9.1. Overview
9.2. Global Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
9.2.1. Advanced Bioinformatic Methods
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 – 2021
9.2.1.3. Market Forecast, 2022 – 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market Estimation, 2015 – 2021
9.2.1.5.1.2. Market Forecast, 2022 – 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market Estimation, 2015 – 2021
9.2.1.5.2.2. Market Forecast, 2022 – 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market Estimation, 2015 – 2021
9.2.1.5.3.2. Market Forecast, 2022 – 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market Estimation, 2015 – 2021
9.2.1.5.4.2. Market Forecast, 2022 – 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market Estimation, 2015 – 2021
9.2.1.5.5.2. Market Forecast, 2022 – 2030
9.2.2. Deep Learning Algorithms
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 – 2021
9.2.2.3. Market Forecast, 2022 – 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market Estimation, 2015 – 2021
9.2.2.5.1.2. Market Forecast, 2022 – 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market Estimation, 2015 – 2021
9.2.2.5.2.2. Market Forecast, 2022 – 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market Estimation, 2015 – 2021
9.2.2.5.3.2. Market Forecast, 2022 – 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market Estimation, 2015 – 2021
9.2.2.5.4.2. Market Forecast, 2022 – 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market Estimation, 2015 – 2021
9.2.2.5.5.2. Market Forecast, 2022 – 2030
9.2.3. Machine Learning
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 – 2021
9.2.3.3. Market Forecast, 2022 – 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market Estimation, 2015 – 2021
9.2.3.5.1.2. Market Forecast, 2022 – 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market Estimation, 2015 – 2021
9.2.3.5.2.2. Market Forecast, 2022 – 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market Estimation, 2015 – 2021
9.2.3.5.3.2. Market Forecast, 2022 – 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market Estimation, 2015 – 2021
9.2.3.5.4.2. Market Forecast, 2022 – 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market Estimation, 2015 – 2021
9.2.3.5.5.2. Market Forecast, 2022 – 2030
9.2.4. Others
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 – 2021
9.2.4.3. Market Forecast, 2022 – 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market Estimation, 2015 – 2021
9.2.4.5.1.2. Market Forecast, 2022 – 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market Estimation, 2015 – 2021
9.2.4.5.2.2. Market Forecast, 2022 – 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market Estimation, 2015 – 2021
9.2.4.5.3.2. Market Forecast, 2022 – 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market Estimation, 2015 – 2021
9.2.4.5.4.2. Market Forecast, 2022 – 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market Estimation, 2015 – 2021
9.2.4.5.5.2. Market Forecast, 2022 – 2030
9.3. Key Segment for Channeling Investments
9.3.1. By Technology
10. Global Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2022 – 2030
10.1. Overview
10.2. Global Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Drugs Design and Redesign
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 – 2021
10.2.1.3. Market Forecast, 2022 – 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 – 2021
10.2.1.5.1.2. Market Forecast, 2022 – 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 – 2021
10.2.1.5.2.2. Market Forecast, 2022 – 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 – 2021
10.2.1.5.3.2. Market Forecast, 2022 – 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 – 2021
10.2.1.5.4.2. Market Forecast, 2022 – 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 – 2021
10.2.1.5.5.2. Market Forecast, 2022 – 2030
10.2.2. Biomarker Development
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 – 2021
10.2.2.3. Market Forecast, 2022 – 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 – 2021
10.2.2.5.1.2. Market Forecast, 2022 – 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 – 2021
10.2.2.5.2.2. Market Forecast, 2022 – 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 – 2021
10.2.2.5.3.2. Market Forecast, 2022 – 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 – 2021
10.2.2.5.4.2. Market Forecast, 2022 – 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 – 2021
10.2.2.5.5.2. Market Forecast, 2022 – 2030
10.2.3. Disease Target Identification
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 – 2021
10.2.3.3. Market Forecast, 2022 – 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 – 2021
10.2.3.5.1.2. Market Forecast, 2022 – 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 – 2021
10.2.3.5.2.2. Market Forecast, 2022 – 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 – 2021
10.2.3.5.3.2. Market Forecast, 2022 – 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 – 2021
10.2.3.5.4.2. Market Forecast, 2022 – 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 – 2021
10.2.3.5.5.2. Market Forecast, 2022 – 2030
10.2.4. Generation of Synthetic Biology (Generative Biology)
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 – 2021
10.2.4.3. Market Forecast, 2022 – 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 – 2021
10.2.4.5.1.2. Market Forecast, 2022 – 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 – 2021
10.2.4.5.2.2. Market Forecast, 2022 – 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 – 2021
10.2.4.5.3.2. Market Forecast, 2022 – 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 – 2021
10.2.4.5.4.2. Market Forecast, 2022 – 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 – 2021
10.2.4.5.5.2. Market Forecast, 2022 – 2030
10.2.5. Novel Molecules (Generative Chemistry) Data
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 – 2021
10.2.5.3. Market Forecast, 2022 – 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 – 2021
10.2.5.5.1.2. Market Forecast, 2022 – 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 – 2021
10.2.5.5.2.2. Market Forecast, 2022 – 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 – 2021
10.2.5.5.3.2. Market Forecast, 2022 – 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 – 2021
10.2.5.5.4.2. Market Forecast, 2022 – 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 – 2021
10.2.5.5.5.2. Market Forecast, 2022 – 2030
10.2.6. Clinical Trial Prediction Outcomes
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 – 2021
10.2.6.3. Market Forecast, 2022 – 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market Estimation, 2015 – 2021
10.2.6.5.1.2. Market Forecast, 2022 – 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market Estimation, 2015 – 2021
10.2.6.5.2.2. Market Forecast, 2022 – 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market Estimation, 2015 – 2021
10.2.6.5.3.2. Market Forecast, 2022 – 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market Estimation, 2015 – 2021
10.2.6.5.4.2. Market Forecast, 2022 – 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market Estimation, 2015 – 2021
10.2.6.5.5.2. Market Forecast, 2022 – 2030
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. Global Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2022 – 2030
11.1. Overview
11.2. Global Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Pharmaceutical Companies
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 – 2021
11.2.1.3. Market Forecast, 2022 – 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market Estimation, 2015 – 2021
11.2.1.5.1.2. Market Forecast, 2022 – 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market Estimation, 2015 – 2021
11.2.1.5.2.2. Market Forecast, 2022 – 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market Estimation, 2015 – 2021
11.2.1.5.3.2. Market Forecast, 2022 – 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market Estimation, 2015 – 2021
11.2.1.5.4.2. Market Forecast, 2022 – 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market Estimation, 2015 – 2021
11.2.1.5.5.2. Market Forecast, 2022 – 2030
11.2.2. Universities and Hospital Networks
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 – 2021
11.2.2.3. Market Forecast, 2022 – 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market Estimation, 2015 – 2021
11.2.2.5.1.2. Market Forecast, 2022 – 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market Estimation, 2015 – 2021
11.2.2.5.2.2. Market Forecast, 2022 – 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market Estimation, 2015 – 2021
11.2.2.5.3.2. Market Forecast, 2022 – 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market Estimation, 2015 – 2021
11.2.2.5.4.2. Market Forecast, 2022 – 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market Estimation, 2015 – 2021
11.2.2.5.5.2. Market Forecast, 2022 – 2030
11.2.3. Cosmetic and Regenerative Medicine Companies
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 – 2021
11.2.3.3. Market Forecast, 2022 – 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market Estimation, 2015 – 2021
11.2.3.5.1.2. Market Forecast, 2022 – 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market Estimation, 2015 – 2021
11.2.3.5.2.2. Market Forecast, 2022 – 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market Estimation, 2015 – 2021
11.2.3.5.3.2. Market Forecast, 2022 – 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market Estimation, 2015 – 2021
11.2.3.5.4.2. Market Forecast, 2022 – 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market Estimation, 2015 – 2021
11.2.3.5.5.2. Market Forecast, 2022 – 2030
11.2.4. Food Companies
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 – 2021
11.2.4.3. Market Forecast, 2022 – 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market Estimation, 2015 – 2021
11.2.4.5.1.2. Market Forecast, 2022 – 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market Estimation, 2015 – 2021
11.2.4.5.2.2. Market Forecast, 2022 – 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market Estimation, 2015 – 2021
11.2.4.5.3.2. Market Forecast, 2022 – 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market Estimation, 2015 – 2021
11.2.4.5.4.2. Market Forecast, 2022 – 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market Estimation, 2015 – 2021
11.2.4.5.5.2. Market Forecast, 2022 – 2030
11.2.5. Research Centers and Laboratories
11.2.5.1. Definition
11.2.5.2. Market Estimation and Penetration, 2015 – 2021
11.2.5.3. Market Forecast, 2022 – 2030
11.2.5.4. Compound Annual Growth Rate (CAGR)
11.2.5.5. Regional Bifurcation
11.2.5.5.1. North America
11.2.5.5.1.1. Market Estimation, 2015 – 2021
11.2.5.5.1.2. Market Forecast, 2022 – 2030
11.2.5.5.2. Europe
11.2.5.5.2.1. Market Estimation, 2015 – 2021
11.2.5.5.2.2. Market Forecast, 2022 – 2030
11.2.5.5.3. Asia Pacific
11.2.5.5.3.1. Market Estimation, 2015 – 2021
11.2.5.5.3.2. Market Forecast, 2022 – 2030
11.2.5.5.4. Middle East and Africa
11.2.5.5.4.1. Market Estimation, 2015 – 2021
11.2.5.5.4.2. Market Forecast, 2022 – 2030
11.2.5.5.5. Latin America
11.2.5.5.5.1. Market Estimation, 2015 – 2021
11.2.5.5.5.2. Market Forecast, 2022 – 2030
11.2.6. Clinicians and Drug Developers
11.2.6.1. Definition
11.2.6.2. Market Estimation and Penetration, 2015 – 2021
11.2.6.3. Market Forecast, 2022 – 2030
11.2.6.4. Compound Annual Growth Rate (CAGR)
11.2.6.5. Regional Bifurcation
11.2.6.5.1. North America
11.2.6.5.1.1. Market Estimation, 2015 – 2021
11.2.6.5.1.2. Market Forecast, 2022 – 2030
11.2.6.5.2. Europe
11.2.6.5.2.1. Market Estimation, 2015 – 2021
11.2.6.5.2.2. Market Forecast, 2022 – 2030
11.2.6.5.3. Asia Pacific
11.2.6.5.3.1. Market Estimation, 2015 – 2021
11.2.6.5.3.2. Market Forecast, 2022 – 2030
11.2.6.5.4. Middle East and Africa
11.2.6.5.4.1. Market Estimation, 2015 – 2021
11.2.6.5.4.2. Market Forecast, 2022 – 2030
11.2.6.5.5. Latin America
11.2.6.5.5.1. Market Estimation, 2015 – 2021
11.2.6.5.5.2. Market Forecast, 2022 – 2030
11.2.7. Others
11.2.7.1. Definition
11.2.7.2. Market Estimation and Penetration, 2015 – 2021
11.2.7.3. Market Forecast, 2022 – 2030
11.2.7.4. Compound Annual Growth Rate (CAGR)
11.2.7.5. Regional Bifurcation
11.2.7.5.1. North America
11.2.7.5.1.1. Market Estimation, 2015 – 2021
11.2.7.5.1.2. Market Forecast, 2022 – 2030
11.2.7.5.2. Europe
11.2.7.5.2.1. Market Estimation, 2015 – 2021
11.2.7.5.2.2. Market Forecast, 2022 – 2030
11.2.7.5.3. Asia Pacific
11.2.7.5.3.1. Market Estimation, 2015 – 2021
11.2.7.5.3.2. Market Forecast, 2022 – 2030
11.2.7.5.4. Middle East and Africa
11.2.7.5.4.1. Market Estimation, 2015 – 2021
11.2.7.5.4.2. Market Forecast, 2022 – 2030
11.2.7.5.5. Latin America
11.2.7.5.5.1. Market Estimation, 2015 – 2021
11.2.7.5.5.2. Market Forecast, 2022 – 2030
11.3. Key Segment for Channeling Investments
11.3.1. By End Users
12. North America Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2020 - 2028
12.1. Overview
12.1.1. North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn)
12.2. North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
12.2.1. Software Solutions
12.2.2. Services
12.3. North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
12.3.1. Advanced Bioinformatic Methods
12.3.2. Deep Learning Algorithms
12.3.3. Machine Learning
12.3.4. Others
12.4. North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Drugs Design and Redesign
12.4.2. Biomarker Development
12.4.3. Disease Target Identification
12.4.4. Generation of Synthetic Biology (Generative Biology)
12.4.5. Novel Molecules (Generative Chemistry) Data
12.4.6. Clinical Trial Prediction Outcomes
12.5. North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Pharmaceutical Companies
12.5.2. Universities and Hospital Networks
12.5.3. Cosmetic and Regenerative Medicine Companies
12.5.4. Food Companies
12.5.5. Research Centers and Laboratories
12.5.6. Clinicians and Drug Developers
12.5.7. Others
12.6. North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
12.6.1.1.1. Software Solutions
12.6.1.1.2. Services
12.6.1.2. U.S Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.1.2.1. Advanced Bioinformatic Methods
12.6.1.2.2. Deep Learning Algorithms
12.6.1.2.3. Machine Learning
12.6.1.2.4. Others
12.6.1.3. U.S Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
12.6.1.3.1. Drugs Design and Redesign
12.6.1.3.2. Biomarker Development
12.6.1.3.3. Disease Target Identification
12.6.1.3.4. Generation of Synthetic Biology (Generative Biology)
12.6.1.3.5. Novel Molecules (Generative Chemistry) Data
12.6.1.3.6. Clinical Trial Prediction Outcomes
12.6.1.4. U.S Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.1.4.1. Pharmaceutical Companies
12.6.1.4.2. Universities and Hospital Networks
12.6.1.4.3. Cosmetic and Regenerative Medicine Companies
12.6.1.4.4. Food Companies
12.6.1.4.5. Research Centers and Laboratories
12.6.1.4.6. Clinicians and Drug Developers
12.6.1.4.7. Others
12.6.2. Canada
12.6.2.1. Canada Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
12.6.2.1.1. Software Solutions
12.6.2.1.2. Services
12.6.2.2. Canada Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.2.2.1. Advanced Bioinformatic Methods
12.6.2.2.2. Deep Learning Algorithms
12.6.2.2.3. Machine Learning
12.6.2.2.4. Others
12.6.2.3. Canada Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
12.6.2.3.1. Drugs Design and Redesign
12.6.2.3.2. Biomarker Development
12.6.2.3.3. Disease Target Identification
12.6.2.3.4. Generation of Synthetic Biology (Generative Biology)
12.6.2.3.5. Novel Molecules (Generative Chemistry) Data
12.6.2.3.6. Clinical Trial Prediction Outcomes
12.6.2.4. Canada Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.2.4.1. Pharmaceutical Companies
12.6.2.4.2. Universities and Hospital Networks
12.6.2.4.3. Cosmetic and Regenerative Medicine Companies
12.6.2.4.4. Food Companies
12.6.2.4.5. Research Centers and Laboratories
12.6.2.4.6. Clinicians and Drug Developers
12.6.2.4.7. Others
12.6.3. Mexico
12.6.3.1. Mexico Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
12.6.3.1.1. Software Solutions
12.6.3.1.2. Services
12.6.3.2. Mexico Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.3.2.1. Advanced Bioinformatic Methods
12.6.3.2.2. Deep Learning Algorithms
12.6.3.2.3. Machine Learning
12.6.3.2.4. Others
12.6.3.3. Mexico Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
12.6.3.3.1. Drugs Design and Redesign
12.6.3.3.2. Biomarker Development
12.6.3.3.3. Disease Target Identification
12.6.3.3.4. Generation of Synthetic Biology (Generative Biology)
12.6.3.3.5. Novel Molecules (Generative Chemistry) Data
12.6.3.3.6. Clinical Trial Prediction Outcomes
12.6.3.4. Mexico Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.3.4.1. Pharmaceutical Companies
12.6.3.4.2. Universities and Hospital Networks
12.6.3.4.3. Cosmetic and Regenerative Medicine Companies
12.6.3.4.4. Food Companies
12.6.3.4.5. Research Centers and Laboratories
12.6.3.4.6. Clinicians and Drug Developers
12.6.3.4.7. Others
12.6.4. Rest of North America
12.6.4.1. Rest of North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
12.6.4.1.1. Software Solutions
12.6.4.1.2. Services
12.6.4.2. Rest of North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
12.6.4.2.1. Advanced Bioinformatic Methods
12.6.4.2.2. Deep Learning Algorithms
12.6.4.2.3. Machine Learning
12.6.4.2.4. Others
12.6.4.3. Rest of North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
12.6.4.3.1. Drugs Design and Redesign
12.6.4.3.2. Biomarker Development
12.6.4.3.3. Disease Target Identification
12.6.4.3.4. Generation of Synthetic Biology (Generative Biology)
12.6.4.3.5. Novel Molecules (Generative Chemistry) Data
12.6.4.3.6. Clinical Trial Prediction Outcomes
12.6.4.4. Rest of North America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
12.6.4.4.1. Pharmaceutical Companies
12.6.4.4.2. Universities and Hospital Networks
12.6.4.4.3. Cosmetic and Regenerative Medicine Companies
12.6.4.4.4. Food Companies
12.6.4.4.5. Research Centers and Laboratories
12.6.4.4.6. Clinicians and Drug Developers
12.6.4.4.7. Others
12.7. Key Segment for Channeling Investments
12.7.1. By Country
12.7.2. By Offerings
12.7.3. By Technology
12.7.4. By Application
12.7.5. By End Users
13. Europe Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2020 - 2028
13.1. Overview
13.1.1. Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn)
13.2. Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.2.1. Software Solutions
13.2.2. Services
13.3. Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.3.1. Advanced Bioinformatic Methods
13.3.2. Deep Learning Algorithms
13.3.3. Machine Learning
13.3.4. Others
13.4. Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Drugs Design and Redesign
13.4.2. Biomarker Development
13.4.3. Disease Target Identification
13.4.4. Generation of Synthetic Biology (Generative Biology)
13.4.5. Novel Molecules (Generative Chemistry) Data
13.4.6. Clinical Trial Prediction Outcomes
13.5. Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Pharmaceutical Companies
13.5.2. Universities and Hospital Networks
13.5.3. Cosmetic and Regenerative Medicine Companies
13.5.4. Food Companies
13.5.5. Research Centers and Laboratories
13.5.6. Clinicians and Drug Developers
13.5.7. Others
13.6. Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.1.1.1. Software Solutions
13.6.1.1.2. Services
13.6.1.2. France Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.1.2.1. Advanced Bioinformatic Methods
13.6.1.2.2. Deep Learning Algorithms
13.6.1.2.3. Machine Learning
13.6.1.2.4. Others
13.6.1.3. France Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.1.3.1. Drugs Design and Redesign
13.6.1.3.2. Biomarker Development
13.6.1.3.3. Disease Target Identification
13.6.1.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.1.3.5. Novel Molecules (Generative Chemistry) Data
13.6.1.3.6. Clinical Trial Prediction Outcomes
13.6.1.4. France Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.1.4.1. Pharmaceutical Companies
13.6.1.4.2. Universities and Hospital Networks
13.6.1.4.3. Cosmetic and Regenerative Medicine Companies
13.6.1.4.4. Food Companies
13.6.1.4.5. Research Centers and Laboratories
13.6.1.4.6. Clinicians and Drug Developers
13.6.1.4.7. Others
13.6.2. The UK
13.6.2.1. The UK Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.2.1.1. Software Solutions
13.6.2.1.2. Services
13.6.2.2. The UK Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.2.2.1. Advanced Bioinformatic Methods
13.6.2.2.2. Deep Learning Algorithms
13.6.2.2.3. Machine Learning
13.6.2.2.4. Others
13.6.2.3. The UK Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.2.3.1. Drugs Design and Redesign
13.6.2.3.2. Biomarker Development
13.6.2.3.3. Disease Target Identification
13.6.2.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.2.3.5. Novel Molecules (Generative Chemistry) Data
13.6.2.3.6. Clinical Trial Prediction Outcomes
13.6.2.4. The UK Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.2.4.1. Pharmaceutical Companies
13.6.2.4.2. Universities and Hospital Networks
13.6.2.4.3. Cosmetic and Regenerative Medicine Companies
13.6.2.4.4. Food Companies
13.6.2.4.5. Research Centers and Laboratories
13.6.2.4.6. Clinicians and Drug Developers
13.6.2.4.7. Others
13.6.3. Spain
13.6.3.1. Spain Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.3.1.1. Software Solutions
13.6.3.1.2. Services
13.6.3.2. Spain Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.3.2.1. Advanced Bioinformatic Methods
13.6.3.2.2. Deep Learning Algorithms
13.6.3.2.3. Machine Learning
13.6.3.2.4. Others
13.6.3.3. Spain Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.3.3.1. Drugs Design and Redesign
13.6.3.3.2. Biomarker Development
13.6.3.3.3. Disease Target Identification
13.6.3.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.3.3.5. Novel Molecules (Generative Chemistry) Data
13.6.3.3.6. Clinical Trial Prediction Outcomes
13.6.3.4. Spain Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.3.4.1. Pharmaceutical Companies
13.6.3.4.2. Universities and Hospital Networks
13.6.3.4.3. Cosmetic and Regenerative Medicine Companies
13.6.3.4.4. Food Companies
13.6.3.4.5. Research Centers and Laboratories
13.6.3.4.6. Clinicians and Drug Developers
13.6.3.4.7. Others
13.6.4. Germany
13.6.4.1. Germany Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.4.1.1. Software Solutions
13.6.4.1.2. Services
13.6.4.2. Germany Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.4.2.1. Advanced Bioinformatic Methods
13.6.4.2.2. Deep Learning Algorithms
13.6.4.2.3. Machine Learning
13.6.4.2.4. Others
13.6.4.3. Germany Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.4.3.1. Drugs Design and Redesign
13.6.4.3.2. Biomarker Development
13.6.4.3.3. Disease Target Identification
13.6.4.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.4.3.5. Novel Molecules (Generative Chemistry) Data
13.6.4.3.6. Clinical Trial Prediction Outcomes
13.6.4.4. Germany Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.4.4.1. Pharmaceutical Companies
13.6.4.4.2. Universities and Hospital Networks
13.6.4.4.3. Cosmetic and Regenerative Medicine Companies
13.6.4.4.4. Food Companies
13.6.4.4.5. Research Centers and Laboratories
13.6.4.4.6. Clinicians and Drug Developers
13.6.4.4.7. Others
13.6.5. Italy
13.6.5.1. Italy Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.5.1.1. Software Solutions
13.6.5.1.2. Services
13.6.5.2. Italy Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.5.2.1. Advanced Bioinformatic Methods
13.6.5.2.2. Deep Learning Algorithms
13.6.5.2.3. Machine Learning
13.6.5.2.4. Others
13.6.5.3. Italy Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.5.3.1. Drugs Design and Redesign
13.6.5.3.2. Biomarker Development
13.6.5.3.3. Disease Target Identification
13.6.5.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.5.3.5. Novel Molecules (Generative Chemistry) Data
13.6.5.3.6. Clinical Trial Prediction Outcomes
13.6.5.4. Italy Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.5.4.1. Pharmaceutical Companies
13.6.5.4.2. Universities and Hospital Networks
13.6.5.4.3. Cosmetic and Regenerative Medicine Companies
13.6.5.4.4. Food Companies
13.6.5.4.5. Research Centers and Laboratories
13.6.5.4.6. Clinicians and Drug Developers
13.6.5.4.7. Others
13.6.6. Nordic Countries
13.6.6.1. Nordic Countries Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.6.1.1. Software Solutions
13.6.6.1.2. Services
13.6.6.2. Nordic Countries Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.6.2.1. Advanced Bioinformatic Methods
13.6.6.2.2. Deep Learning Algorithms
13.6.6.2.3. Machine Learning
13.6.6.2.4. Others
13.6.6.3. Nordic Countries Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.6.3.1. Drugs Design and Redesign
13.6.6.3.2. Biomarker Development
13.6.6.3.3. Disease Target Identification
13.6.6.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.6.3.5. Novel Molecules (Generative Chemistry) Data
13.6.6.3.6. Clinical Trial Prediction Outcomes
13.6.6.4. Nordic Countries Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.6.4.1. Pharmaceutical Companies
13.6.6.4.2. Universities and Hospital Networks
13.6.6.4.3. Cosmetic and Regenerative Medicine Companies
13.6.6.4.4. Food Companies
13.6.6.4.5. Research Centers and Laboratories
13.6.6.4.6. Clinicians and Drug Developers
13.6.6.4.7. Others
13.6.6.5. Nordic Countries Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux Union
13.6.7.1. Benelux Union Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.7.1.1. Software Solutions
13.6.7.1.2. Services
13.6.7.2. Benelux Union Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.7.2.1. Advanced Bioinformatic Methods
13.6.7.2.2. Deep Learning Algorithms
13.6.7.2.3. Machine Learning
13.6.7.2.4. Others
13.6.7.3. Benelux Union Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.7.3.1. Drugs Design and Redesign
13.6.7.3.2. Biomarker Development
13.6.7.3.3. Disease Target Identification
13.6.7.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.7.3.5. Novel Molecules (Generative Chemistry) Data
13.6.7.3.6. Clinical Trial Prediction Outcomes
13.6.7.4. Benelux Union Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.7.4.1. Pharmaceutical Companies
13.6.7.4.2. Universities and Hospital Networks
13.6.7.4.3. Cosmetic and Regenerative Medicine Companies
13.6.7.4.4. Food Companies
13.6.7.4.5. Research Centers and Laboratories
13.6.7.4.6. Clinicians and Drug Developers
13.6.7.4.7. Others
13.6.7.5. Benelux Union Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of Europe
13.6.8.1. Rest of Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
13.6.8.1.1. Software Solutions
13.6.8.1.2. Services
13.6.8.2. Rest of Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
13.6.8.2.1. Advanced Bioinformatic Methods
13.6.8.2.2. Deep Learning Algorithms
13.6.8.2.3. Machine Learning
13.6.8.2.4. Others
13.6.8.3. Rest of Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
13.6.8.3.1. Drugs Design and Redesign
13.6.8.3.2. Biomarker Development
13.6.8.3.3. Disease Target Identification
13.6.8.3.4. Generation of Synthetic Biology (Generative Biology)
13.6.8.3.5. Novel Molecules (Generative Chemistry) Data
13.6.8.3.6. Clinical Trial Prediction Outcomes
13.6.8.4. Rest of Europe Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
13.6.8.4.1. Pharmaceutical Companies
13.6.8.4.2. Universities and Hospital Networks
13.6.8.4.3. Cosmetic and Regenerative Medicine Companies
13.6.8.4.4. Food Companies
13.6.8.4.5. Research Centers and Laboratories
13.6.8.4.6. Clinicians and Drug Developers
13.6.8.4.7. Others
13.7. Key Segment for Channeling Investments
13.7.1. By Country
13.7.2. By Offerings
13.7.3. By Technology
13.7.4. By Application
13.7.5. By End Users
14. Asia Pacific Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2020 - 2028
14.1. Overview
14.1.1. Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn)
14.2. Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.2.1. Software Solutions
14.2.2. Services
14.3. Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.3.1. Advanced Bioinformatic Methods
14.3.2. Deep Learning Algorithms
14.3.3. Machine Learning
14.3.4. Others
14.4. Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Drugs Design and Redesign
14.4.2. Biomarker Development
14.4.3. Disease Target Identification
14.4.4. Generation of Synthetic Biology (Generative Biology)
14.4.5. Novel Molecules (Generative Chemistry) Data
14.4.6. Clinical Trial Prediction Outcomes
14.5. Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Pharmaceutical Companies
14.5.2. Universities and Hospital Networks
14.5.3. Cosmetic and Regenerative Medicine Companies
14.5.4. Food Companies
14.5.5. Research Centers and Laboratories
14.5.6. Clinicians and Drug Developers
14.5.7. Others
14.6. Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.1.1.1. Software Solutions
14.6.1.1.2. Services
14.6.1.2. China Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.1.2.1. Advanced Bioinformatic Methods
14.6.1.2.2. Deep Learning Algorithms
14.6.1.2.3. Machine Learning
14.6.1.2.4. Others
14.6.1.3. China Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.1.3.1. Drugs Design and Redesign
14.6.1.3.2. Biomarker Development
14.6.1.3.3. Disease Target Identification
14.6.1.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.1.3.5. Novel Molecules (Generative Chemistry) Data
14.6.1.3.6. Clinical Trial Prediction Outcomes
14.6.1.4. China Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.1.4.1. Pharmaceutical Companies
14.6.1.4.2. Universities and Hospital Networks
14.6.1.4.3. Cosmetic and Regenerative Medicine Companies
14.6.1.4.4. Food Companies
14.6.1.4.5. Research Centers and Laboratories
14.6.1.4.6. Clinicians and Drug Developers
14.6.1.4.7. Others
14.6.2. Japan
14.6.2.1. Japan Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.2.1.1. Software Solutions
14.6.2.1.2. Services
14.6.2.2. Japan Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.2.2.1. Advanced Bioinformatic Methods
14.6.2.2.2. Deep Learning Algorithms
14.6.2.2.3. Machine Learning
14.6.2.2.4. Others
14.6.2.3. Japan Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.2.3.1. Drugs Design and Redesign
14.6.2.3.2. Biomarker Development
14.6.2.3.3. Disease Target Identification
14.6.2.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.2.3.5. Novel Molecules (Generative Chemistry) Data
14.6.2.3.6. Clinical Trial Prediction Outcomes
14.6.2.4. Japan Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.2.4.1. Pharmaceutical Companies
14.6.2.4.2. Universities and Hospital Networks
14.6.2.4.3. Cosmetic and Regenerative Medicine Companies
14.6.2.4.4. Food Companies
14.6.2.4.5. Research Centers and Laboratories
14.6.2.4.6. Clinicians and Drug Developers
14.6.2.4.7. Others
14.6.3. India
14.6.3.1. India Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.3.1.1. Software Solutions
14.6.3.1.2. Services
14.6.3.2. India Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.3.2.1. Advanced Bioinformatic Methods
14.6.3.2.2. Deep Learning Algorithms
14.6.3.2.3. Machine Learning
14.6.3.2.4. Others
14.6.3.3. India Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.3.3.1. Drugs Design and Redesign
14.6.3.3.2. Biomarker Development
14.6.3.3.3. Disease Target Identification
14.6.3.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.3.3.5. Novel Molecules (Generative Chemistry) Data
14.6.3.3.6. Clinical Trial Prediction Outcomes
14.6.3.4. India Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.3.4.1. Pharmaceutical Companies
14.6.3.4.2. Universities and Hospital Networks
14.6.3.4.3. Cosmetic and Regenerative Medicine Companies
14.6.3.4.4. Food Companies
14.6.3.4.5. Research Centers and Laboratories
14.6.3.4.6. Clinicians and Drug Developers
14.6.3.4.7. Others
14.6.4. New Zealand
14.6.4.1. New Zealand Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.4.1.1. Software Solutions
14.6.4.1.2. Services
14.6.4.2. New Zealand Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.4.2.1. Advanced Bioinformatic Methods
14.6.4.2.2. Deep Learning Algorithms
14.6.4.2.3. Machine Learning
14.6.4.2.4. Others
14.6.4.3. New Zealand Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.4.3.1. Drugs Design and Redesign
14.6.4.3.2. Biomarker Development
14.6.4.3.3. Disease Target Identification
14.6.4.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.4.3.5. Novel Molecules (Generative Chemistry) Data
14.6.4.3.6. Clinical Trial Prediction Outcomes
14.6.4.4. New Zealand Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.4.4.1. Pharmaceutical Companies
14.6.4.4.2. Universities and Hospital Networks
14.6.4.4.3. Cosmetic and Regenerative Medicine Companies
14.6.4.4.4. Food Companies
14.6.4.4.5. Research Centers and Laboratories
14.6.4.4.6. Clinicians and Drug Developers
14.6.4.4.7. Others
14.6.5. Australia
14.6.5.1. Australia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.5.1.1. Software Solutions
14.6.5.1.2. Services
14.6.5.2. Australia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.5.2.1. Advanced Bioinformatic Methods
14.6.5.2.2. Deep Learning Algorithms
14.6.5.2.3. Machine Learning
14.6.5.2.4. Others
14.6.5.3. Australia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.5.3.1. Drugs Design and Redesign
14.6.5.3.2. Biomarker Development
14.6.5.3.3. Disease Target Identification
14.6.5.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.5.3.5. Novel Molecules (Generative Chemistry) Data
14.6.5.3.6. Clinical Trial Prediction Outcomes
14.6.5.4. Australia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.5.4.1. Pharmaceutical Companies
14.6.5.4.2. Universities and Hospital Networks
14.6.5.4.3. Cosmetic and Regenerative Medicine Companies
14.6.5.4.4. Food Companies
14.6.5.4.5. Research Centers and Laboratories
14.6.5.4.6. Clinicians and Drug Developers
14.6.5.4.7. Others
14.6.6. South Korea
14.6.6.1. South Korea Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.6.1.1. Software Solutions
14.6.6.1.2. Services
14.6.6.2. South Korea Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.6.2.1. Advanced Bioinformatic Methods
14.6.6.2.2. Deep Learning Algorithms
14.6.6.2.3. Machine Learning
14.6.6.2.4. Others
14.6.6.3. South Korea Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.6.3.1. Drugs Design and Redesign
14.6.6.3.2. Biomarker Development
14.6.6.3.3. Disease Target Identification
14.6.6.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.6.3.5. Novel Molecules (Generative Chemistry) Data
14.6.6.3.6. Clinical Trial Prediction Outcomes
14.6.6.4. South Korea Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.6.4.1. Pharmaceutical Companies
14.6.6.4.2. Universities and Hospital Networks
14.6.6.4.3. Cosmetic and Regenerative Medicine Companies
14.6.6.4.4. Food Companies
14.6.6.4.5. Research Centers and Laboratories
14.6.6.4.6. Clinicians and Drug Developers
14.6.6.4.7. Others
14.6.7. Southeast Asia
14.6.7.1. Southeast Asia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.7.1.1. Software Solutions
14.6.7.1.2. Services
14.6.7.2. Southeast Asia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.7.2.1. Advanced Bioinformatic Methods
14.6.7.2.2. Deep Learning Algorithms
14.6.7.2.3. Machine Learning
14.6.7.2.4. Others
14.6.7.3. Southeast Asia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.7.3.1. Drugs Design and Redesign
14.6.7.3.2. Biomarker Development
14.6.7.3.3. Disease Target Identification
14.6.7.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.7.3.5. Novel Molecules (Generative Chemistry) Data
14.6.7.3.6. Clinical Trial Prediction Outcomes
14.6.7.4. Southeast Asia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.7.4.1. Pharmaceutical Companies
14.6.7.4.2. Universities and Hospital Networks
14.6.7.4.3. Cosmetic and Regenerative Medicine Companies
14.6.7.4.4. Food Companies
14.6.7.4.5. Research Centers and Laboratories
14.6.7.4.6. Clinicians and Drug Developers
14.6.7.4.7. Others
14.6.7.5. Southeast Asia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1. Rest of Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
14.6.8.1.1. Software Solutions
14.6.8.1.2. Services
14.6.8.2. Rest of Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
14.6.8.2.1. Advanced Bioinformatic Methods
14.6.8.2.2. Deep Learning Algorithms
14.6.8.2.3. Machine Learning
14.6.8.2.4. Others
14.6.8.3. Rest of Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
14.6.8.3.1. Drugs Design and Redesign
14.6.8.3.2. Biomarker Development
14.6.8.3.3. Disease Target Identification
14.6.8.3.4. Generation of Synthetic Biology (Generative Biology)
14.6.8.3.5. Novel Molecules (Generative Chemistry) Data
14.6.8.3.6. Clinical Trial Prediction Outcomes
14.6.8.4. Rest of Asia Pacific Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
14.6.8.4.1. Pharmaceutical Companies
14.6.8.4.2. Universities and Hospital Networks
14.6.8.4.3. Cosmetic and Regenerative Medicine Companies
14.6.8.4.4. Food Companies
14.6.8.4.5. Research Centers and Laboratories
14.6.8.4.6. Clinicians and Drug Developers
14.6.8.4.7. Others
14.7. Key Segment for Channeling Investments
14.7.1. By Country
14.7.2. By Offerings
14.7.3. By Technology
14.7.4. By Application
14.7.5. By End Users
15. Middle East and Africa Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2020 - 2028
15.1. Overview
15.1.1. Middle East and Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn)
15.2. Middle East and Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.2.1. Software Solutions
15.2.2. Services
15.3. Middle East and Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.3.1. Advanced Bioinformatic Methods
15.3.2. Deep Learning Algorithms
15.3.3. Machine Learning
15.3.4. Others
15.4. Middle East and Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.4.1. Drugs Design and Redesign
15.4.2. Biomarker Development
15.4.3. Disease Target Identification
15.4.4. Generation of Synthetic Biology (Generative Biology)
15.4.5. Novel Molecules (Generative Chemistry) Data
15.4.6. Clinical Trial Prediction Outcomes
15.5. Middle East and Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Pharmaceutical Companies
15.5.2. Universities and Hospital Networks
15.5.3. Cosmetic and Regenerative Medicine Companies
15.5.4. Food Companies
15.5.5. Research Centers and Laboratories
15.5.6. Clinicians and Drug Developers
15.5.7. Others
15.6. Middle East and Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1. Saudi Arabia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.6.1.1.1. Software Solutions
15.6.1.1.2. Services
15.6.1.2. Saudi Arabia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.1.2.1. Advanced Bioinformatic Methods
15.6.1.2.2. Deep Learning Algorithms
15.6.1.2.3. Machine Learning
15.6.1.2.4. Others
15.6.1.3. Saudi Arabia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.6.1.3.1. Drugs Design and Redesign
15.6.1.3.2. Biomarker Development
15.6.1.3.3. Disease Target Identification
15.6.1.3.4. Generation of Synthetic Biology (Generative Biology)
15.6.1.3.5. Novel Molecules (Generative Chemistry) Data
15.6.1.3.6. Clinical Trial Prediction Outcomes
15.6.1.4. Saudi Arabia Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.1.4.1. Pharmaceutical Companies
15.6.1.4.2. Universities and Hospital Networks
15.6.1.4.3. Cosmetic and Regenerative Medicine Companies
15.6.1.4.4. Food Companies
15.6.1.4.5. Research Centers and Laboratories
15.6.1.4.6. Clinicians and Drug Developers
15.6.1.4.7. Others
15.6.2. UAE
15.6.2.1. UAE Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.6.2.1.1. Software Solutions
15.6.2.1.2. Services
15.6.2.2. UAE Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.2.2.1. Advanced Bioinformatic Methods
15.6.2.2.2. Deep Learning Algorithms
15.6.2.2.3. Machine Learning
15.6.2.2.4. Others
15.6.2.3. UAE Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.6.2.3.1. Drugs Design and Redesign
15.6.2.3.2. Biomarker Development
15.6.2.3.3. Disease Target Identification
15.6.2.3.4. Generation of Synthetic Biology (Generative Biology)
15.6.2.3.5. Novel Molecules (Generative Chemistry) Data
15.6.2.3.6. Clinical Trial Prediction Outcomes
15.6.2.4. UAE Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.2.4.1. Pharmaceutical Companies
15.6.2.4.2. Universities and Hospital Networks
15.6.2.4.3. Cosmetic and Regenerative Medicine Companies
15.6.2.4.4. Food Companies
15.6.2.4.5. Research Centers and Laboratories
15.6.2.4.6. Clinicians and Drug Developers
15.6.2.4.7. Others
15.6.3. Egypt
15.6.3.1. Egypt Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.6.3.1.1. Software Solutions
15.6.3.1.2. Services
15.6.3.2. Egypt Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.3.2.1. Advanced Bioinformatic Methods
15.6.3.2.2. Deep Learning Algorithms
15.6.3.2.3. Machine Learning
15.6.3.2.4. Others
15.6.3.3. Egypt Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.6.3.3.1. Drugs Design and Redesign
15.6.3.3.2. Biomarker Development
15.6.3.3.3. Disease Target Identification
15.6.3.3.4. Generation of Synthetic Biology (Generative Biology)
15.6.3.3.5. Novel Molecules (Generative Chemistry) Data
15.6.3.3.6. Clinical Trial Prediction Outcomes
15.6.3.4. Egypt Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.3.4.1. Pharmaceutical Companies
15.6.3.4.2. Universities and Hospital Networks
15.6.3.4.3. Cosmetic and Regenerative Medicine Companies
15.6.3.4.4. Food Companies
15.6.3.4.5. Research Centers and Laboratories
15.6.3.4.6. Clinicians and Drug Developers
15.6.3.4.7. Others
15.6.4. Kuwait
15.6.4.1. Kuwait Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.6.4.1.1. Software Solutions
15.6.4.1.2. Services
15.6.4.2. Kuwait Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.4.2.1. Advanced Bioinformatic Methods
15.6.4.2.2. Deep Learning Algorithms
15.6.4.2.3. Machine Learning
15.6.4.2.4. Others
15.6.4.3. Kuwait Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.6.4.3.1. Drugs Design and Redesign
15.6.4.3.2. Biomarker Development
15.6.4.3.3. Disease Target Identification
15.6.4.3.4. Generation of Synthetic Biology (Generative Biology)
15.6.4.3.5. Novel Molecules (Generative Chemistry) Data
15.6.4.3.6. Clinical Trial Prediction Outcomes
15.6.4.4. Kuwait Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.4.4.1. Pharmaceutical Companies
15.6.4.4.2. Universities and Hospital Networks
15.6.4.4.3. Cosmetic and Regenerative Medicine Companies
15.6.4.4.4. Food Companies
15.6.4.4.5. Research Centers and Laboratories
15.6.4.4.6. Clinicians and Drug Developers
15.6.4.4.7. Others
15.6.5. South Africa
15.6.5.1. South Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.6.5.1.1. Software Solutions
15.6.5.1.2. Services
15.6.5.2. South Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.5.2.1. Advanced Bioinformatic Methods
15.6.5.2.2. Deep Learning Algorithms
15.6.5.2.3. Machine Learning
15.6.5.2.4. Others
15.6.5.3. South Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.6.5.3.1. Drugs Design and Redesign
15.6.5.3.2. Biomarker Development
15.6.5.3.3. Disease Target Identification
15.6.5.3.4. Generation of Synthetic Biology (Generative Biology)
15.6.5.3.5. Novel Molecules (Generative Chemistry) Data
15.6.5.3.6. Clinical Trial Prediction Outcomes
15.6.5.4. South Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.5.4.1. Pharmaceutical Companies
15.6.5.4.2. Universities and Hospital Networks
15.6.5.4.3. Cosmetic and Regenerative Medicine Companies
15.6.5.4.4. Food Companies
15.6.5.4.5. Research Centers and Laboratories
15.6.5.4.6. Clinicians and Drug Developers
15.6.5.4.7. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1. Rest of Middle East & Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
15.6.6.1.1. Software Solutions
15.6.6.1.2. Services
15.6.6.2. Rest of Middle East & Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
15.6.6.2.1. Advanced Bioinformatic Methods
15.6.6.2.2. Deep Learning Algorithms
15.6.6.2.3. Machine Learning
15.6.6.2.4. Others
15.6.6.3. Rest of Middle East & Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
15.6.6.3.1. Drugs Design and Redesign
15.6.6.3.2. Biomarker Development
15.6.6.3.3. Disease Target Identification
15.6.6.3.4. Generation of Synthetic Biology (Generative Biology)
15.6.6.3.5. Novel Molecules (Generative Chemistry) Data
15.6.6.3.6. Clinical Trial Prediction Outcomes
15.6.6.4. Rest of Middle East & Africa Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Pharmaceutical Companies
15.6.6.4.2. Universities and Hospital Networks
15.6.6.4.3. Cosmetic and Regenerative Medicine Companies
15.6.6.4.4. Food Companies
15.6.6.4.5. Research Centers and Laboratories
15.6.6.4.6. Clinicians and Drug Developers
15.6.6.4.7. Others
15.7. Key Segment for Channeling Investments
15.7.1. By Country
15.7.2. By Offerings
15.7.3. By Technology
15.7.4. By Application
15.7.5. By End Users
16. Latin America Artificial Intelligence in Life Extension Market Analysis and Forecasts, 2020 - 2028
16.1. Overview
16.1.1. Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn)
16.2. Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
16.2.1. Software Solutions
16.2.2. Services
16.3. Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
16.3.1. Advanced Bioinformatic Methods
16.3.2. Deep Learning Algorithms
16.3.3. Machine Learning
16.3.4. Others
16.4. Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Drugs Design and Redesign
16.4.2. Biomarker Development
16.4.3. Disease Target Identification
16.4.4. Generation of Synthetic Biology (Generative Biology)
16.4.5. Novel Molecules (Generative Chemistry) Data
16.4.6. Clinical Trial Prediction Outcomes
16.5. Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Pharmaceutical Companies
16.5.2. Universities and Hospital Networks
16.5.3. Cosmetic and Regenerative Medicine Companies
16.5.4. Food Companies
16.5.5. Research Centers and Laboratories
16.5.6. Clinicians and Drug Developers
16.5.7. Others
16.6. Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
16.6.1.1.1. Software Solutions
16.6.1.1.2. Services
16.6.1.2. Brazil Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.1.2.1. Advanced Bioinformatic Methods
16.6.1.2.2. Deep Learning Algorithms
16.6.1.2.3. Machine Learning
16.6.1.2.4. Others
16.6.1.3. Brazil Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
16.6.1.3.1. Drugs Design and Redesign
16.6.1.3.2. Biomarker Development
16.6.1.3.3. Disease Target Identification
16.6.1.3.4. Generation of Synthetic Biology (Generative Biology)
16.6.1.3.5. Novel Molecules (Generative Chemistry) Data
16.6.1.3.6. Clinical Trial Prediction Outcomes
16.6.1.4. Brazil Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.1.4.1. Pharmaceutical Companies
16.6.1.4.2. Universities and Hospital Networks
16.6.1.4.3. Cosmetic and Regenerative Medicine Companies
16.6.1.4.4. Food Companies
16.6.1.4.5. Research Centers and Laboratories
16.6.1.4.6. Clinicians and Drug Developers
16.6.1.4.7. Others
16.6.2. Argentina
16.6.2.1. Argentina Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
16.6.2.1.1. Software Solutions
16.6.2.1.2. Services
16.6.2.2. Argentina Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.2.2.1. Advanced Bioinformatic Methods
16.6.2.2.2. Deep Learning Algorithms
16.6.2.2.3. Machine Learning
16.6.2.2.4. Others
16.6.2.3. Argentina Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
16.6.2.3.1. Drugs Design and Redesign
16.6.2.3.2. Biomarker Development
16.6.2.3.3. Disease Target Identification
16.6.2.3.4. Generation of Synthetic Biology (Generative Biology)
16.6.2.3.5. Novel Molecules (Generative Chemistry) Data
16.6.2.3.6. Clinical Trial Prediction Outcomes
16.6.2.4. Argentina Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.2.4.1. Pharmaceutical Companies
16.6.2.4.2. Universities and Hospital Networks
16.6.2.4.3. Cosmetic and Regenerative Medicine Companies
16.6.2.4.4. Food Companies
16.6.2.4.5. Research Centers and Laboratories
16.6.2.4.6. Clinicians and Drug Developers
16.6.2.4.7. Others
16.6.3. Rest of Latin America
16.6.3.1. Rest of Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Offerings
16.6.3.1.1. Software Solutions
16.6.3.1.2. Services
16.6.3.2. Rest of Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Technology
16.6.3.2.1. Advanced Bioinformatic Methods
16.6.3.2.2. Deep Learning Algorithms
16.6.3.2.3. Machine Learning
16.6.3.2.4. Others
16.6.3.3. Rest of Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By Application
16.6.3.3.1. Drugs Design and Redesign
16.6.3.3.2. Biomarker Development
16.6.3.3.3. Disease Target Identification
16.6.3.3.4. Generation of Synthetic Biology (Generative Biology)
16.6.3.3.5. Novel Molecules (Generative Chemistry) Data
16.6.3.3.6. Clinical Trial Prediction Outcomes
16.6.3.4. Rest of Latin America Artificial Intelligence in Life Extension Market Revenue (US$ Mn) and Forecasts, By End Users
16.6.3.4.1. Pharmaceutical Companies
16.6.3.4.2. Universities and Hospital Networks
16.6.3.4.3. Cosmetic and Regenerative Medicine Companies
16.6.3.4.4. Food Companies
16.6.3.4.5. Research Centers and Laboratories
16.6.3.4.6. Clinicians and Drug Developers
16.6.3.4.7. Others
16.7. Key Segment for Channeling Investments
16.7.1. By Country
16.7.2. By Offerings
16.7.3. By Technology
16.7.4. By Application
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Market Share Analysis, 2021
17.2. Global Presence and Growth Strategies
17.2.1. Mergers and Acquisitions
17.2.2. Product Launches
17.2.3. Investments Trends
17.2.4. R&D Initiatives
18. Player Profiles
18.1. Juvenescence Ltd.
18.1.1. Company Details
18.1.2. Company Overview
18.1.3. Product Offerings
18.1.4. Key Developments
18.1.5. Financial Analysis
18.1.6. SWOT Analysis
18.1.7. Business Strategies
18.2. Life Extension (Insilico Medicine)
18.2.1. Company Details
18.2.2. Company Overview
18.2.3. Product Offerings
18.2.4. Key Developments
18.2.5. Financial Analysis
18.2.6. SWOT Analysis
18.2.7. Business Strategies
18.3. Human Longevity, Inc.
18.3.1. Company Details
18.3.2. Company Overview
18.3.3. Product Offerings
18.3.4. Key Developments
18.3.5. Financial Analysis
18.3.6. SWOT Analysis
18.3.7. Business Strategies
18.4. AgeX Therapeutics, Inc.
18.4.1. Company Details
18.4.2. Company Overview
18.4.3. Product Offerings
18.4.4. Key Developments
18.4.5. Financial Analysis
18.4.6. SWOT Analysis
18.4.7. Business Strategies
18.5. UNITY Biotechnology
18.5.1. Company Details
18.5.2. Company Overview
18.5.3. Product Offerings
18.5.4. Key Developments
18.5.5. Financial Analysis
18.5.6. SWOT Analysis
18.5.7. Business Strategies
18.6. resTORbio
18.6.1. Company Details
18.6.2. Company Overview
18.6.3. Product Offerings
18.6.4. Key Developments
18.6.5. Financial Analysis
18.6.6. SWOT Analysis
18.6.7. Business Strategies
18.7. Samumed
18.7.1. Company Details
18.7.2. Company Overview
18.7.3. Product Offerings
18.7.4. Key Developments
18.7.5. Financial Analysis
18.7.6. SWOT Analysis
18.7.7. Business Strategies
18.8. Other Market Participants
19. Key Findings
Note: This
ToC is tentative and can be changed according to the research study conducted
during the course of report completion.
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
